Some industries have made a name for themselves by being the best at being the worst. They sell products with a known body count, they have undermined science with fake experts, and they have bullied and manipulated legislatures into low-oversight, low-tax schemes that crippled public health response for a century or longer. And now they want in on the newest legal drug market—marijuana.
In mid-March 2021, the Coalition for Cannabis Policy, Education, and Regulation was launched, funded and overseen by a coalition of companies that include representatives from Big Alcohol (Constellation Brands and Molson Coors) and Big Tobacco (Altria, formerly Philip Morris). The Coalition explicitly states its intention to “guide cannabis legalization and regulation at the federal level.”
This is not a philanthropic effort. In-house industry documents show that the tobacco industry has been planning for the legalization of marijuana for the past fifty years, hoping to use it to boost flagging tobacco sales. Meanwhile, Constellation has already moved aggressively into the marijuana industry, obtaining a significant stake in medical marijuana brand Canopy. Molson Coors has also already forged a partnership with marijuana companies to develop a line of CBD products.
The Coalition touts its expertise in “regulatory and enforcement structures, state and legacy systems, financing and minority capital access, tax policy, criminal justice reform, [and] social equity … .” These are not empty claims. For over a century, Big Alcohol and Big Tobacco have created lasting harm in each of these domains. They have undermined regulatory schema. They have consolidated small companies to create transnational behemoths. Through endless lobbying and bottomless campaign coffers, they have crippled community abilities to offset harms by raising alcohol or tobacco taxes. By shifted liability for alcohol harms away from the companies and sales environments and on to individual consumers, they have made it cripplingly difficult to hold businesses accountable. Both alcohol and tobacco companies have invested billions in targeting ethnic, racial, and sexual minority groups.
In short, in every single one of these domains of expertise, Big Alcohol and Big Tobacco have mastered the art of increasing harm.
Responsible marijuana legislation simply cannot coexist with Big Alcohol or Big Tobacco’s interests. In terms of preventable causes of death worldwide, tobacco and alcohol use have rank first and third, even during the height of the opioid crisis. Even above the simple profit motive, evidence shows that mixing these industries with marijuana increases harms from the latter. Recent studies suggest that using alcohol with marijuana substantially increases the level of intoxication versus using either alone. Similarly, tobacco and marijuana co-users have a tougher time quitting either. This Coalition must either ban alcohol and tobacco interests, or make it clear where their interests lie: in making money and burying bodies.
READ MORE about the need to keep Big Alcohol out of the marijuana industry.
READ MORE about the lobbying power of Big Alcohol.
By Ramón Castellblanch, PhD
The COVID-19 pandemic aggravated the opioid epidemic, both in terms of supply and demand. In terms of the supply, we took a terrible hit in the number of programs to fight it. As of September, their revenues were down by over 20%. With those losses, more than half of these programs were not sure that they’d still be operating this spring.
At the same time, demand for substance use disorder (SUD) treatment skyrocketed under the COVID-19 pandemic. For the last three quarters reported, California’s opioid dashboard shows that opioid overdose deaths rose from 882 in the final quarter of 2019 to 1,255 in the second quarter of 2020, an increase of over 40%.
On the bright side, the state of California took some serious steps toward addressing the crisis. Its most notable achievement was in the area of funding SUD treatment. The enactment of SB 855 means that private insurers must cover it. At this beginning of this year, the state Department of Managed Health Care has directed the insurers to submit forms documenting their compliance by February 1.
Global Health Organization Calls on Allies to Craft New Plan for Stopping Alcohol Harm
As Big Alcohol expand its reach across every continent, international cooperation becomes critical to protecting public health. No organizations have the capacity for coordination that the World Health Organization (WHO) does, and it is promising that they have identified alcohol harm as a priority. For over a decade, the organization has relied on a Global Strategy to Reduce the Harmful Use of Alcohol and targeted a 10% reduction in member states’ alcohol consumption. Nonetheless, WHO’s own evaluators drily note that it is “unlikely” that any members states will reach that benchmark. Clearly it is time to reassess the strategy.
Conscious of this, the WHO issued a call for comment on a new iteration of the Global Strategy. Alcohol Justice and the California Alcohol Prevention Alliance were both invited to contribute. The letters of comment are attached below, but both emphasized:
1. The need for aggressive opposition towards the global alcohol industry.
2. An emphasis on social justice and equity when assessing alcohol impact and prevention, and amplifying the voices of indigenous minorities, LGBTQ communities, and other vulnerable populations.
3. CAPA and AJ project priorities, including Charge For Harm, advertising restrictions, and tighter control of products designed to promote overconsumption and youth access.
“We’re a small part of a worldwide fight,” said Carson Benowitz-Fredericks, Research Manager for Alcohol Justice, “against a very strong industry. But there are a lot of us across the globe. The WHO Global Strategy gives us a blueprint for coming together, pushing back, and saving lives.”
READ MORE – the original WHO Global Strategy to Reduce the Harmful Use of Alcohol document.
READ MORE – CAPA’s comments on the WHO Global Strategy.
READ MORE – Alcohol Justice’s comments on the WHO Global Strategy.
PASSED | FAILED | |
AJ Supported | 3 | 11 |
AJ Opposed | 7 | 6 |
CAPA Supported | 1 | 2 |
CAPA Opposed | 1 | 1 |
GET ACTION ALERTS AND eNEWS |
STAY CONNECTED |
CONTACT US 24 Belvedere St. San Rafael, CA 94901 415-456-5692 |
SUPPORT US Terms of Service & Privacy Policy |